RIA
UTHR icon

Realta Investment Advisors’s United Therapeutics UTHR Stock Holding History

Realta Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-750
Closed -$88K – 1813
2019
Q1 		$88K Buy
+750
New +$87.4K 0.04% 417

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Realta Investment Advisors's UTHR Position: Q2 2019 in Review

Realta Investment Advisors sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 750 shares — an estimated $88K sold.

Realta Investment Advisors first reported a position in UTHR in Q1 2019 and held it in 1 quarter. The position peaked at $88K in Q1 2019. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • Realta Investment Advisors reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Realta Investment Advisors sold 750 United Therapeutics shares in Q2 2019, an estimated $88K.
  • Realta Investment Advisors first reported a position in United Therapeutics in Q1 2019 and held it in 1 quarter.
  • Realta Investment Advisors's United Therapeutics position peaked at $88K in Q1 2019.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Realta Investment Advisors's 13F filing for Q2 2019, filed 1 Aug 2019.